STRATA Skin Sciences (SSKN) Current Deferred Revenue (2012 - 2025)

STRATA Skin Sciences' Current Deferred Revenue history runs 14 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Current Deferred Revenue changed 0.31% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (changed 0.31% YoY), while the FY2025 annual figure was $2.2 million, changed 0.31% from the prior year.
• Current Deferred Revenue came in at $2.2 million for Q4 2025 at STRATA Skin Sciences, down from $2.6 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $3.8 million in Q3 2021 to a low of $2.1 million in Q4 2023.
• A 5-year average of $2.6 million and a median of $2.4 million in 2023 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue surged 132.84% in 2021 and decreased 25.12% in 2023, its largest moves.
• STRATA Skin Sciences' Current Deferred Revenue stood at $3.3 million in 2021, then declined by 15.43% to $2.8 million in 2022, then fell by 23.69% to $2.1 million in 2023, then increased by 5.71% to $2.2 million in 2024, then advanced by 0.31% to $2.2 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.2 million, $2.6 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison